U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 181

Tests names and labsConditionsGenes, analytes, and microbesMethods

Fragile X syndrome, 300624, X-linked dominant (Fragile X syndrome) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Fragile X syndrome, 300624, X-linked dominant (Fragile X syndrome)(Repeat Analysis)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • T Targeted variant analysis

Fragile X syndrome, 300624, X-linked dominant (Fragile X syndrome) (Prenatal)(Repeat Analysis)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • T Targeted variant analysis

Fragile X syndrome, 300624, X-linked dominant (Fragile X syndrome) (Prenatal) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Fragile X Syndrome, Repeat Number Analysis with Reflex to Methylation Analysis

Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital
United States
61
  • M Methylation analysis
  • T Targeted variant analysis

Whole Genome Sequencing

24 Genetics 24Genetics SL
Spain
91
  • C Sequence analysis of the entire coding region

Fragile X - Related Disorders

Center for Genetics at Saint Francis Saint Francis Hospital
United States
11
  • T Targeted variant analysis

Fragile X Syndrome

Genetics Laboratory Shodair Children's Hospital
United States
11
  • M Methylation analysis
  • T Targeted variant analysis

Fragile X CGG Repeat Expansion Analysis

Sanford Medical Genetics Laboratory Sanfordhealth
United States
31
  • M Methylation analysis
  • T Targeted variant analysis

Carrier Screening - Comprehensive Panel (145 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
185145
  • D Deletion/duplication analysis
  • I Microsatellite instability testing (MSI)
  • X Mutation scanning of select exons
  • T Targeted variant analysis

Carrier Screening - Fragile X Syndrome (FMR1)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
31
  • I Microsatellite instability testing (MSI)

Fragile X Syndrome, Mol. Analysis

Mayo Clinic Laboratories Mayo Clinic
United States
41
  • M Methylation analysis
  • T Targeted variant analysis

qChip 1M

Quantitative Genomic Medicine Laboratories, SL
Spain
184162
  • D Deletion/duplication analysis

qChip 60k post-natal

Quantitative Genomic Medicine Laboratories, SL
Spain
184162
  • D Deletion/duplication analysis

qChip 400

Quantitative Genomic Medicine Laboratories, SL
Spain
184162
  • D Deletion/duplication analysis

Fragile X syndrome (FMR1 gene)

Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS
Chile
11
  • T Targeted variant analysis

Fragile X Syndrome Testing

UAB Medical Genomics Laboratory UAB Medicine
United States
11
  • M Methylation analysis

EPISign Whole Genome Methylation Assay

Molecular Genetics Laboratory London Health Sciences Centre
Canada
191
  • M Methylation analysis

NewbornGeneID

GeneID Lab - Advanced Molecular Diagnostics
United States
7361
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

High-Resolution Rapid Microarray (CGH and SNP)

Allele Diagnostics
United States
247231
  • D Deletion/duplication analysis
  • H Detection of homozygosity

Results: 1 to 20 of 181

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.